CN1970065A - Medicament for treating hyperplasia of prostate - Google Patents
Medicament for treating hyperplasia of prostate Download PDFInfo
- Publication number
- CN1970065A CN1970065A CNA2006101283111A CN200610128311A CN1970065A CN 1970065 A CN1970065 A CN 1970065A CN A2006101283111 A CNA2006101283111 A CN A2006101283111A CN 200610128311 A CN200610128311 A CN 200610128311A CN 1970065 A CN1970065 A CN 1970065A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicament
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicinal composition for treating prostate diseases, which is prepared from the following raw materials (by weight proportion): rhubarb horsetails, peach kernels, baikal skullcap root, burred tuber, zedoary, licorice root, dried rehmannia root, root of herbaceous peony, gadfly, centipede, leeches, buthus martensi karsch, pangolin scales, blood clam shell, apricot seeds, wood louse, poria cocos wolf, the beneficial effects of the invention include quick effect, short course of treatment, low recurrence rate, no toxic and side actions.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of prostatosis, relate in particular to a kind of medicine for the treatment of prostatic hyperplasia.
Background technology
Prostatic hyperplasia (hypertrophy) is the elderly men common disease, and in recent years, sickness rate increases gradually, prostatic hyperplasia (hypertrophy) blocks owing to causing at urinary system though symptom is a benign lesion, and it is not smooth to urinate, directly influence renal function, patient's health and life brought serious harm.Prostatic hyperplasia (hypertrophy) is thought the impairment caused by overstrain kidney essense according to theory of Chinese medical science, and being invaded by exogenous pathogen or internal and external factor interweave, cause the operation of three warmers water liquid and gasify not normal and take place, and as impairment of purifying and descending function of the lung, the bladder of can not regulating fluid apssage making a bet, spleen loses and transfers, can not ascending the clear and descending the turbid; The gasification function of kidney is not normal, and is open unfavorable; In addition, stagnation of QI due to depression of the liver, blood stasis obstruction etc.All can influence qiactivity of triple energizer and cause the difficulty in urination.At present, a lot of to the Therapeutic Method of prostatic hyperplasia (hypertrophy) disease, as: traditional operation, the operation of gasification TURP, microwave, interventional therapy, Western medicine etc., treatment has a big risk, expense height, poor effect.And this patient mostly is advanced age, and other complication are more, and the gerontal patient is difficult to bear.
Summary of the invention
The medicine that the purpose of this invention is to provide good, the with strong points treatment prostatic hyperplasia of a kind of therapeutic effect.
The present invention realizes above-mentioned purpose by the following technical solutions: a kind of medicine for the treatment of prostatic hyperplasia, and it is the medicament of being made by the raw material of following parts by weight:
Radix Et Rhizoma Rhei 8~15 Semen Persicaes 6~15 Radix Scutellariaes 8~15 rhizoma sparganic 8~15
Rhizoma Curcumae 8~15 Radix Glycyrrhizaes 6~12 Radix Rehmanniae 20~40 Radix Paeoniae Albas 10~20
Tabanus 2~5 Scolopendras 2~5 Hirudos 2~5 Scorpios 5~8
Squama Manis 10~20 Holotrichia diomphalia Batess 2~5 Concha Arcaes 12~20 Semen Armeniacae Amarums 6~15
Eupolyphaga Seu Steleophaga 5~10 Poria 10~20.
The medicine of treatment prostatic hyperplasia, the preferably medicament of making by the raw material of following parts by weight:
Radix Et Rhizoma Rhei 698~12 Semen Persicaes 8~12 Radix Scutellariaes 8~12 rhizoma sparganic 8~12
Rhizoma Curcumae 8~12 Radix Glycyrrhizaes 8~12 Radix Rehmanniae 25~35 Radix Paeoniae Albas 12~18
Tabanus 2~3 Scolopendras 2~3 Hirudos 2~3 Scorpios 6~8
Squama Manis 12~18 Holotrichia diomphalia Batess 2~3 Concha Arcaes 12~18 Semen Armeniacae Amarums 8~12
Eupolyphaga Seu Steleophaga 5~8 Poria 12~18.
The medicine of treatment prostatic hyperplasia, the most preferably medicament of making by the raw material of following parts by weight:
Radix Et Rhizoma Rhei 10 Semen Persicaes 10 Radix Scutellariaes 10 rhizoma sparganic 10
Rhizoma Curcumae 10 Radix Glycyrrhizaes 10 Radix Rehmanniae 30 Radix Paeoniae Albas 15
Tabanus 2 Scolopendras 3 Hirudos 3 Scorpios 6
Squama Manis 15 Holotrichia diomphalia Batess 3 Concha Arcaes 15 Semen Armeniacae Amarums 9
Eupolyphaga Seu Steleophaga 6 Poria 15.
The concocting method of each raw material components:
1, Radix Et Rhizoma Rhei: little fire is fried to yellow in the pot.
2, Tabanus, Scolopendra: pulverize and make Tabanus powder, Scolopendra powder.
3, Squama Manis: the clear husky little fire of companion is fried to yellow back and is sprayed airing with white vinegar in the pot.
4, Holotrichia diomphalia Bates: little fire is fried to yellow in the pot.
5, Semen Armeniacae Amarum: little fire is fried little yellow in the pot.
Medicament of the present invention is a said dosage form on any pharmaceutics.
The preparation of common formulations:
1, mixture: above-mentioned each component drug is mixed, decoct with water leaching, behind fried liquid placement certain hour, leach insoluble matter, collect filtrate concentrating, the packing of concentrated solution cold filtration.
2, capsule: with above-mentioned each material medicine drying and crushing, mix, sieving incapsulates in the shell.
3, pill: above-mentioned each component drug is ground into smalls, adds Mel and make honeyed pill.
Among the present invention, Radix Rehmanniae, Radix Glycyrrhizae are selected Radix Rehmanniae, Radix Glycyrrhizae for use, and Radix et Rhizoma Rhei (processed), Semen Persicae have activating blood and removing stasis, removing heat from blood, detoxifcation, blood pressure lowering, expansion peripheral vessels, blood flow increasing; Radix Scutellariae heat clearing away bath is wet, diuresis, hemostasis, calmness, blood pressure lowering; Rhizoma sparganic, Rhizoma Curcumae, Squama Manis preparata, Eupolyphaga Seu Steleophaga, Holotrichia diomphalia Bates be even removing blood stasis, removing food stagnancy pain relieving; Particularly Rhizoma Curcumae has anticancer effect; Scolopendra, the Scorpio spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., removing obstruction in the collateral to relieve pain, detoxicating and resolving stagnation of pathogens; Tabanus, Hirudo have the removing blood stasis of invigorating blood circulation, the effect of the diffusing piece of eliminating stagnation; The Radix Rehmanniae clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting; The pain relieving of Radix Paeoniae Alba suppressing the hyperactive liver, astringing YIN to stop sweating; The Poria promoting diuresis to eliminate damp pathogen, spleen-benefiting mind-tranquilizing; Concha Arcae, Semen Armeniacae Amarum removing food stagnancy collateral dredging, flat lung; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, detoxifcation.More than each medicine compatibility removing blood stasis, the removing food stagnancy pain relieving, the detumescence of purging heat, promoting diuresis to eliminate damp pathogen, hard masses softening and resolving, this prescription is taken safety, has no side effect instant effect, short treating period, taking convenience.
The specific embodiment
The present invention enumerates 6 embodiment, and the parts by weight of each embodiment component see the following form:
Component | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
Radix et Rhizoma Rhei (processed) | 10 | 8 | 12 | 15 | 10 | 12 |
Semen Persicae | 10 | 15 | 12 | 6 | 8 | 15 |
Radix Scutellariae | 10 | 12 | 15 | 12 | 15 | 8 |
Rhizoma sparganic | 10 | 8 | 10 | 15 | 12 | 15 |
Rhizoma Curcumae | 10 | 15 | 12 | 8 | 15 | 10 |
Radix Glycyrrhizae | 10 | 8 | 15 | 10 | 12 | 8 |
Radix Rehmanniae | 30 | 40 | 20 | 30 | 25 | 35 |
The Radix Paeoniae Alba | 15 | 10 | 20 | 12 | 18 | 15 |
The Tabanus powder | 2 | 3 | 5 | 4 | 2 | 3 |
The Scolopendra powder | 3 | 2 | 5 | 3 | 4 | 2 |
Hirudo | 3 | 2 | 5 | 3 | 4 | 2 |
Scorpio | 6 | 5 | 8 | 7 | 6 | 5 |
Squama Manis preparata | 10 | 20 | 15 | 12 | 18 | 12 |
Holotrichia diomphalia Bates (stir-fry) | 3 | 2 | 5 | 4 | 3 | 2 |
Concha Arcae | 15 | 12 | 20 | 15 | 12 | 18 |
Semen Armeniacae Amarum (stir-fry) | 9 | 10 | 15 | 6 | 8 | 12 |
Eupolyphaga Seu Steleophaga | 6 | 10 | 5 | 8 | 8 | 9 |
Poria | 15 | 10 | 18 | 16 | 20 | 12 |
Clinical experiment case of the present invention is totally 76 people, age 60-85 year, according to inspections such as prostate B ultrasonic, cystoscope, anus touch, gets rid of after neurogenic bladder, carcinoma of prostate, the injury of urethra narrow in ghost image rehearse with musical accompaniment urine and interventional therapy difficulty person.Be and take the capsule that medicine of the present invention is made merely, capsule is No. 0 capsule, each heavy 0.5g, and each oral 4, three times on the one, 10 days is a course of treatment.
Oral medicine of the present invention is after 3 courses of treatment, through the phone inquiry and follow up a case by regular visits to the doorstep, except that have 3 routine patients invalid, all the other all controlled micturition all are significantly improved or cure.The prostate ultrasound diagnosis finds that its volume is more preceding and dwindles (being about 1/3rd) to some extent, and residual urine obviously reduces or disappears, and nocturia is generally below 3 times often, and urine waits for, urinate and interrupt and the dripping symptom in urine back obviously alleviates or disappears.
Therapeutic outcome sees the following form:
The transference cure case | The sx case | Case takes effect | Invalid case | |
First course of treatment | 2 | 12 | 34 | 15 |
Second course of treatment | 3 | 24 | 43 | 12 |
The 3rd course of treatment | 8 | 37 | 36 | 3 |
From last table, wherein, 8 routine controlled micturition recover normal, account for 10% of total routine number; 37 its symptoms of routine patient greatly alleviate, and account for 50% of total routine number; 28 routine patient's symptoms alleviate slightly, account for 36% of total routine number; 3 routine patients are invalid, account for 4% of total routine number; Total effective rate is 96%.
Claims (4)
1, a kind of medicine for the treatment of prostatic hyperplasia is characterized in that, it is the medicament of being made by the raw material of following parts by weight:
Radix Et Rhizoma Rhei 8~15 Semen Persicaes 6~15 Radix Scutellariaes 8~15 rhizoma sparganic 8~15
Rhizoma Curcumae 8~15 Radix Glycyrrhizaes 6~12 Radix Rehmanniae 20~40 Radix Paeoniae Albas 10~20
Tabanus 2~5 Scolopendras 2~5 Hirudos 2~5 Scorpios 5~8
Squama Manis 10~20 Holotrichia diomphalia Batess 2~5 Concha Arcaes 12~20 Semen Armeniacae Amarums 6~15
Eupolyphaga Seu Steleophaga 5~10 Poria 10~20.
2, treat the medicine of prostatic hyperplasia according to claim 1, it is characterized in that, it is the medicament of being made by the raw material of following parts by weight:
Radix Et Rhizoma Rhei 8~12 Semen Persicaes 8~12 Radix Scutellariaes 8~12 rhizoma sparganic 8~12
Rhizoma Curcumae 8~12 Radix Glycyrrhizaes 8~12 Radix Rehmanniae 25~35 Radix Paeoniae Albas 12~18
Tabanus 2~3 Scolopendras 2~3 Hirudos 2~3 Scorpios 6~8
Squama Manis 12~18 Holotrichia diomphalia Batess 2~3 Concha Arcaes 12~1 8 Semen Armeniacae Amarums 8~12
Eupolyphaga Seu Steleophaga 5~8 Poria 12~18.
3, as the medicine of treatment prostatic hyperplasia as described in the claim 2, it is characterized in that it is the medicament of being made by the raw material of following parts by weight:
Radix Et Rhizoma Rhei 10 Semen Persicaes 10 Radix Scutellariaes 10 rhizoma sparganic 10
Rhizoma Curcumae 10 Radix Glycyrrhizaes 10 Radix Rehmanniae 30 Radix Paeoniae Albas 15
Tabanus 2 Scolopendras 3 Hirudos 3 Scorpios 6
Squama Manis 15 Holotrichia diomphalia Batess 3 Concha Arcaes 15 Semen Armeniacae Amarums 9
Eupolyphaga Seu Steleophaga 6 Poria 15.
4, as the medicine of treatment prostatic hyperplasia as described in any one of the claim 1~3, it is characterized in that described medicament is a said dosage form on any pharmaceutics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101283111A CN100435840C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating hyperplasia of prostate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101283111A CN100435840C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating hyperplasia of prostate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1970065A true CN1970065A (en) | 2007-05-30 |
CN100435840C CN100435840C (en) | 2008-11-26 |
Family
ID=38111213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101283111A Expired - Fee Related CN100435840C (en) | 2006-11-30 | 2006-11-30 | Medicament for treating hyperplasia of prostate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100435840C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773643A (en) * | 2010-03-04 | 2010-07-14 | 刘国津 | Chinese medicine preparation for treating mammary gland proliferation diseases and preparation method thereof |
CN103750478A (en) * | 2013-12-09 | 2014-04-30 | 安徽圣芝堂生物科技有限公司 | Prostate health functional drink |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1057453C (en) * | 1995-10-23 | 2000-10-18 | 张克忠 | Tongniaoling for diuresis |
CN1562313A (en) * | 2004-04-12 | 2005-01-12 | 北京乾露春科技有限公司 | effervesce tablet of rheum and ground beetle, and preparation method |
-
2006
- 2006-11-30 CN CNB2006101283111A patent/CN100435840C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773643A (en) * | 2010-03-04 | 2010-07-14 | 刘国津 | Chinese medicine preparation for treating mammary gland proliferation diseases and preparation method thereof |
CN101773643B (en) * | 2010-03-04 | 2012-06-06 | 刘国津 | Chinese medicine preparation for treating mammary gland proliferation diseases and preparation method thereof |
CN103750478A (en) * | 2013-12-09 | 2014-04-30 | 安徽圣芝堂生物科技有限公司 | Prostate health functional drink |
Also Published As
Publication number | Publication date |
---|---|
CN100435840C (en) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN101406635B (en) | Chinese medicine decoction for treating stranguria and eliminating stone | |
CN102225181B (en) | Medicament for treating benign prostatic hyperplasia disease and preparation method thereof | |
CN108969642A (en) | A kind of Chinese medicine compound prescription external preparation that treating chronic prostatitis and its preparation process | |
CN101112533B (en) | Chinese traditional medicine composition for treating and preventing gout and method of making the same | |
CN104147536A (en) | Medicine composition for treating haemorrhoids and preparation method thereof | |
CN100435840C (en) | Medicament for treating hyperplasia of prostate | |
CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
CN102961575A (en) | Formula of traditional Chinese medicine for treating viral cardiac neurosis | |
CN103007227B (en) | Drug for treating kidney calculus, and preparation method thereof | |
CN102335370A (en) | Flavored medicinal composition for removing stasis and dredging collaterals, and preparation method thereof | |
CN101829188B (en) | Medicament for treating urinary infection and lithiasis | |
CN101530572B (en) | Gastro-enteritis decoction | |
CN102940674B (en) | Medicine composition for treating benign prostatic hyperplasia | |
CN103495122A (en) | Traditional Chinese medicine for treating urolithiasis | |
CN101391074B (en) | Medicine composition for treating digestive system carcinoma and preparation method thereof | |
CN109260307B (en) | A Chinese medicinal composition with calculus removing effect, and its preparation method | |
CN106668787A (en) | Traditional Chinese medicine honeyed pill for treating hepatonecrosis and liver cancer and preparation method of traditional Chinese medicine honeyed pill | |
CN102302639B (en) | Traditional Chinese medicine composition for treating retention of urine | |
CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
CN105796676A (en) | Pills for effectively treating fatty liver | |
CN105250807A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN110538251A (en) | Traditional Chinese medicine composition for treating prostate diseases and preparation method and application thereof | |
CN117018131A (en) | Traditional Chinese medicine composition for treating persistent HPV infection and preparation method thereof | |
CN102698126A (en) | Traditional Chinese medicine compound having effect of treating prostatitis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081126 Termination date: 20091230 |